Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Helioson logo — A biopharmaceutical pioneer dedicated to creating groundbrea...

Helioson

A biopharmaceutical pioneer dedicated to creating groundbreaking therapies for cancer.

Founded 2021 Seed Total: $10.00M Biopharma, Biotechnology +1

General Information

Company Name Helioson
Founded Year 2021
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Helioson. To contact Helioson, visit shcyyy.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Helioson

Helioson, a **biopharmaceutical** pioneer founded in **2021**, is dedicated to creating groundbreaking therapies for cancer. The company's slogan, "A biopharmaceutical pioneer dedicated to creating groundbreaking therapies for cancer," reflects its commitment to innovation in the field of **cancer treatment**. Helioson focuses on developing chemically innovative drugs for anti-tumor indications within the **Biopharma, Biotechnology, and Pharmaceutical** industries. In a significant milestone, Helioson secured a **CNY10.00M Seed Round** investment on **21 September 2023** from **Yuandong Biological Investment Management**. This funding is indicative of the confidence that investors place in Helioson's potential to drive advancements in cancer treatment through its innovative drug development initiatives. This recent investment is poised to support the company's ongoing efforts in developing novel therapies for tackling cancer. As a **biopharmaceutical company** at the forefront of cancer treatment innovation, Helioson's focus on pioneering therapies and its successful **Seed Round** investment from **Yuandong Biological Investment Management** position it favorably within the industry's landscape. This recent investment is expected to catalyze Helioson's trajectory in advancing the development of groundbreaking anti-tumor drugs, further establishing the company as a key player in the field of biopharmaceuticals.

Taxonomy: biopharmaceutical, oncology, therapies, cancer, drug development, chemically innovative, anti-tumor, pharmaceutical research, precision medicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round CNY10.00M 1
Yuandong Biological Investment Management
21 Sep 2023

Helioson Alternatives & Competitors

Helioson vs
Odyssey Thera
Odyssey Thera

Pioneering cellular pharmacology to discover groundbreaking cancer therapies.

Venture round
11-50 employees
Biopharma, Biotechnology
Helioson vs
MACROPHAGE PHARMA LIMITED
MACROPHAGE PHARMA LIMITED

Empowering the immune system to combat cancer with precision-targeted therapies

Series A
Biotechnology, Pharmaceutical
Compare Helioson vs MACROPHAGE PHARMA LIMITED
Helioson vs
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc. United States

A late-stage clinical biopharmaceutical company focused on developing novel therapies for a range of...

Post-IPO Equity
18 employees
Biopharma, Biotechnology
Also compare with: Helioson vs Cage Pharma Cage Pharma

FAQ About Helioson

A biopharmaceutical pioneer dedicated to creating groundbreaking therapies for cancer.
Helioson was founded in 2021.
Helioson operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on biopharmaceutical, oncology, therapies and cancer.
Helioson has completed 1 funding round, raising a total of $10.00M. The latest funding stage is Seed.
Top alternatives and competitors to Helioson include Odyssey Thera, MACROPHAGE PHARMA LIMITED, SELLAS Life Sciences Group, Inc., Cage Pharma, Apollomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Helioson and Odyssey Thera are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Helioson, https://bouncewatch.com/company/helioson, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes